Substrates for peptidase M12.217: ADAM17 peptidase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40S ribosomal protein S12 | P63323 | 2-132 | peptide-Lys23+Thr-peptide | N | MS | Glu | Val | Leu | Lys | Thr | Ala | Leu | Ile | Scharfenberg et al., 2020 | ||
| 40S ribosomal protein S14 | P62264 | 1-151 | peptide-Met75+Leu-peptide | N | MS | Tyr | Ala | Ala | Met | Leu | Ala | Ala | Gln | Scharfenberg et al., 2020 | ||
| 40S ribosomal protein S3a (Protein TU-11) | P97351 | 1-264 | peptide-Glu230+Leu-peptide | N | MS | Lys | Leu | Met | Glu | Leu | His | Gly | Glu | Scharfenberg et al., 2020 | ||
| Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Dpa | Abz-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Ser-Arg-Dpa | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Guan et al., 2010 | |||||
| Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | P60710 | 1-375 | peptide-Ala7+Leu-peptide | N | MS | Asp | Ile | Ala | Ala | Leu | Val | Val | Asp | Scharfenberg et al., 2020 | ||
| Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | P63260 | 1-375 | peptide-Leu8+Val-peptide | N | MS | Ile | Ala | Ala | Leu | Val | Ile | Asp | Asn | Scharfenberg et al., 2020 | ||
| ADAM17 isoform 2 precursor | Q9Z0F8-2 | 18-655 | peptide-His118+Val-peptide | N | MS | Phe | Ser | Gly | His | Val | Val | Gly | Glu | Scharfenberg et al., 2020 | ||
| ADAM17 isoform 2 precursor | Q9Z0F8-2 | 18-655 | peptide-Ala129+His-peptide | N | MS | Arg | Val | Leu | Ala | His | Ile | Gly | Asp | Scharfenberg et al., 2020 | ||
| ADAM17 isoform 2 precursor | Q9Z0F8-2 | 18-655 | peptide-Glu463+Ser-peptide | N | MS | Lys | Thr | Ile | Glu | Ser | Lys | Ala | Gln | Scharfenberg et al., 2020 | ||
| ADAM17 isoform 2 precursor | Q9Z0F8-2 | 18-655 | peptide-Leu165+Val-peptide | N | MS | Lys | Arg | Met | Leu | Val | Tyr | Lys | Ser | Scharfenberg et al., 2020 | ||
| Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) | Q8BGQ7 | 1-968 | peptide-Ala803+Thr-peptide | N | MS | Glu | Ala | Leu | Ala | Thr | Ala | Val | Ile | Scharfenberg et al., 2020 | ||
| amphiregulin | P15514 | 101-184 | peptide-Lys187+Thr-peptide | N | Lys | Ser | Met | Lys | Thr | His | Ser | Met | Hinkle et al., 2004 | 19484 | ||
| amphiregulin | P15514 | 101-184 | peptide-Gln99+Val-peptide | P | Arg | Val | Glu | Gln | Val | Val | Lys | Pro | Hinkle et al., 2004 | 19485 | ||
| amphiregulin precursor | P31955 | 27-248 | peptide-Lys180+Thr-peptide | P | Lys | Ser | Met | Lys | Thr | His | Ser | Glu | Hinkle et al., 2004 | |||
| amphiregulin precursor | P31955 | 27-248 | peptide-Asn82+Glu-peptide | P | Glu | Tyr | Asp | Asn | Glu | Pro | Gln | Ile | Hinkle et al., 2004 | 20161 | ||
| amphiregulin precursor | P31955 | 27-248 | peptide-Gln99+Val-peptide | P | Arg | Val | Glu | Gln | Val | Ile | Lys | Pro | Hinkle et al., 2004 | |||
| amyloid beta A4 protein | P05067 | 18-770 | peptide-Lys687+Leu-peptide | P | His | His | Gln | Lys | Leu | Val | Phe | Phe | Mohan et al., 2002 | 19275 | ||
| Amyloid beta A4 protein | P05067-4 | 18-770 | peptide-Val636+Ile-peptide | P | MS | Gly | Gly | Val | Val | Ile | Ala | Thr | Val | Hata et al., 2009 | ||
| Amyloid beta A4 protein | P05067-4 | 18-770 | peptide-Ala638+Thr-peptide | P | MS | Val | Val | Ile | Ala | Thr | Val | Ile | Val | Hata et al., 2009 | ||
| Amyloid beta A4 protein | P05067-4 | 18-770 | peptide-Lys612+Leu-peptide | P | MS | His | His | Gln | Lys | Leu | Val | Phe | Phe | Hata et al., 2009 | ||
| Angiotensin-converting enzyme | P12821 | 30-1306 | peptide-Arg1203+Ser-peptide | P | Asn | Ser | Ala | Arg | Ser | Glu | Gly | Pro | Corvol et al., 2004 | 16947 | ||
| angiotensin-converting enzyme peptidase, Isoform Testis-specific | P12822-2 | 33-737 | peptide-Arg631+Ser-peptide | P | Asn | Ser | Ala | Arg | Ser | Glu | Gly | Ser | Corvol et al., 2004 | 16948 | ||
| Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) | Q99NH0-3 | 1-1599 | peptide-Ala+Val-peptide | N | MS | Ala | Ala | Ala | Ala | Val | Ala | Ala | Pro | Scharfenberg et al., 2020 | ||
| Apoptosis-associated speck-like protein containing a CARD (mASC) (PYD and CARD domain-containing protein) | Q9EPB4 | 1-193 | peptide-Ala98+Ala-peptide | N | MS | Val | Ala | Ala | Ala | Ala | Ser | Val | Pro | Scharfenberg et al., 2020 | ||
| ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) | P56480 | 47-529 | peptide-Asn146+Val-peptide | N | MS | Arg | Ile | Met | Asn | Val | Ile | Gly | Glu | Scharfenberg et al., 2020 | ||
| ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (mHEL-5) (Nuclear DNA helicase II) (NDH II) | O70133-2 | 1-1380 | peptide-Ala119+Leu-peptide | N | MS | Pro | His | Leu | Ala | Leu | Lys | Ala | Glu | Scharfenberg et al., 2020 | ||
| beta-1 adrenergic receptor | P08588 | 1-477 | peptide-Arg31+Leu-peptide | P | NT | Thr | Ala | Ala | Arg | Leu | Leu | Val | Pro | Zhu & Steinberg, 2021 | ||
| Btc | Q05928 | 32-177 | peptide-Tyr111+Leu-peptide | P | Asp | Leu | Phe | Tyr | Leu | Gln | Gln | Asp | Hinkle et al., 2004 | 19487 | ||
| BTC betacellulin | P35070 | 106-117 | peptide-Tyr111+Leu-peptide | N | Asp | Leu | Phe | Tyr | Leu | Arg | Gly | Asp | Sunnarborg et al., 2002 | 26300 | ||
| c-{kit} ligand-1 cleavage site peptide | Leu-Pro-Pro-Val-Ala-Ala+Ser-Ser-Leu-Arg | N | Pro | Val | Ala | Ala | Ser | Ser | Leu | Arg | Zou et al., 2004 | |||||
| Cadherin-2 (Neural cadherin) (N-cadherin) (CD antigen CD325) | P15116 | 160-906 | peptide-Thr386+Phe-peptide | N | MS | Thr | Ala | Met | Thr | Phe | Tyr | Gly | Glu | Scharfenberg et al., 2020 | ||
| Calsyntenin-1 | O94985-2 | 29 -971 | peptide-His814+Met-peptide | P | MS | His | Ala | Asn | His | Met | Ala | Ala | Gln | Hata et al., 2009 | ||
| Calsyntenin-1 | O94985-2 | 29 -971 | peptide-Ala816+Ala-peptide | P | MS | Asn | His | Met | Ala | Ala | Gln | Pro | Gln | Hata et al., 2009 | ||
| Calsyntenin-1 | O94985-2 | 29 -971 | peptide-Thr851+Val-peptide | P | MS | Ser | Thr | Ala | Thr | Val | Val | Ile | Val | Hata et al., 2009 | ||
| Calsyntenin-1 | O94985-2 | 29 -971 | peptide-Ile854+Val-peptide | P | MS | Thr | Val | Val | Ile | Val | Val | Cys | Val | Hata et al., 2009 | ||
| Calsyntenin-2 | Q9H4D0 | 21-955 | peptide-His803+Leu-peptide | P | MS | His | Val | Asn | His | Leu | Ile | Val | Gln | Hata et al., 2009 | ||
| Calsyntenin-2 | Q9H4D0 | 21-955 | peptide-Thr834+Val-peptide | P | MS | Ser | Ile | Ala | Thr | Val | Val | Ile | Ile | Hata et al., 2009 | ||
| Calsyntenin-2 | Q9H4D0 | 21-955 | peptide-Ile837+Ile-peptide | P | MS | Thr | Val | Val | Ile | Ile | Ile | Ser | Val | Hata et al., 2009 | ||
| Calsyntenin-3 | Q9BQT9 | 20-956 | peptide-His812+Val-peptide | P | MS | His | Pro | Ser | His | Val | Leu | Ser | Ser | Hata et al., 2009 | ||
| Calsyntenin-3 | Q9BQT9 | 20-956 | peptide-Thr849+Leu-peptide | P | MS | Ser | Ala | Ala | Thr | Leu | Ile | Ile | Val | Hata et al., 2009 | ||
| Calsyntenin-3 | Q9BQT9 | 20-956 | peptide-Ile852+Val-peptide | P | MS | Thr | Leu | Ile | Ile | Val | Val | Cys | Val | Hata et al., 2009 | ||
| Cellular nucleic acid-binding protein (CNBP) (Zinc finger protein 9) | P53996-2 | 2-178 | peptide-Phe38+Val-peptide | N | MS | Gly | Phe | Gln | Phe | Val | Ser | Ser | Ser | Scharfenberg et al., 2020 | ||
| Clathrin light chain A (Lca) | O08585 | 1-235 | peptide-Arg101+Leu-peptide | N | MS | Glu | Val | Asp | Arg | Leu | Gln | Ser | Glu | Scharfenberg et al., 2020 | ||
| Coiled-coil domain-containing protein 124 | Q9D8X2 | 1-217 | peptide-Ala147+Val-peptide | N | MS | Asp | Ala | Ile | Ala | Val | Leu | Ser | Val | Scharfenberg et al., 2020 | ||
| Collagen alpha-2(IV) chain [Cleaved into: Canstatin] | P08122 | 184-1707 | peptide-Lys1391+Ile-peptide | N | MS | Ile | Pro | Gln | Lys | Ile | Ala | Val | Gln | Scharfenberg et al., 2020 | ||
| Crk-like protein | P47941 | 1-303 | peptide-Ser112+Val-peptide | N | MS | Pro | Val | Gly | Ser | Val | Ser | Ala | Pro | Scharfenberg et al., 2020 | ||
| Cystatin-C (Cystatin-3) | P21460 | 21-140 | peptide-Met29+Leu-peptide | N | MS | Gly | Pro | Arg | Met | Leu | Gly | Ala | Pro | Scharfenberg et al., 2020 | ||
| Cysteine-rich protein 1 (CRP-1) (Cysteine-rich intestinal protein) (CRIP) | P63254 | 1-77 | peptide-Arg16+Val-peptide | N | MS | Phe | Ala | Glu | Arg | Val | Thr | Ser | Leu | Scharfenberg et al., 2020 | ||
| Dabcyl-Leu-Ala-Gln-Ala-HPh-Arg-Ser-Lys(Fam)-NH2 | Dabcyl-Leu-Ala-Gln-Ala+HPh-Arg-Ser-Lys(Fam)-NH2 | S | Leu | Ala | Gln | Ala | HPh | Arg | Ser | LyN | Moss & Rasmussen, 2007 | |||||
| Dabcyl-Pro-Arg-Ala-Ala-Ala-hPhe-Thr-Ser-Pro-Lys(FAM)-NH2 | Dabcyl-Pro-Arg-Ala-Ala-Ala+homoPhe-Thr-Ser-Pro-Lys(FAM)-NH2 | S | Arg | Ala | Ala | Ala | HPh | Thr | Ser | Pro | Moss et al., 2016 | |||||
| Dabcyl-Pro-Cha-Gly-Cys(Me)-His-Ala-Lys(Fam)-NH2 | Dabcyl-Pro-Cha-Gly+Cys(Me)-His-Ala-Lys(Fam)-NH2 | S | Dab | Pro | Cha | Gly | CyM | His | Ala | LyN | Moss & Rasmussen, 2007 | |||||
| Dabcyl-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Lys(FAM)-NH2 | Dabcyl-Ser-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Lys(FAM)-NH2 | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Moss et al., 2016 | |||||
| Dickkopf-related protein 3 (Dickkopf-3) (Dkk-3) (mDkk-3) | Q9QUN9 | 23-349 | peptide-Thr131+Val-peptide | N | MS | Phe | Ser | Glu | Thr | Val | Ile | Thr | Ser | Scharfenberg et al., 2020 | ||
| Dihydropyrimidinase-related protein 2 (DRP-2) (Unc-33-like phosphoprotein 2) (ULIP-2) | O08553 | 1-572 | peptide-Pro523+Ala-peptide | N | MS | Lys | Thr | Ser | Pro | Ala | Lys | Gln | Gln | Scharfenberg et al., 2020 | ||
| DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28) | P97310 | 2-904 | peptide-Arg133+Gly-peptide | N | MS | Arg | Met | Arg | Arg | Gly | Leu | Leu | Tyr | Scharfenberg et al., 2020 | ||
| DNA replication licensing factor MCM6 (EC 3.6.4.12) (Mis5 homolog) | P97311 | 1-821 | peptide-Ala232+Val-peptide | N | MS | Arg | Ala | Glu | Ala | Val | Glu | Ser | Ala | Scharfenberg et al., 2020 | ||
| Dnp-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-NH2 | Dnp-Ser-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Ser-Arg-NH2 | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Black, 2004 | |||||
| Dnp-Ser-Pro-Leu-Ala-Gln-Phe-Val-Arg-Ser-Ser-Ser-Arg-NH2 | Dnp-Ser-Pro-Leu-Ala-Gln-Phe+Val-Arg-Ser-Ser-Ser-Arg-NH2 | S | Leu | Ala | Gln | Phe | Val | Arg | Ser | Ser | Black, 2004 | |||||
| Echinoderm microtubule-associated protein-like 4 (EMAP-4) | Q3UMY5-4 | 1-988 | peptide-Pro804+Leu-peptide | N | MS | Pro | Ser | Leu | Pro | Leu | Thr | Gly | Thr | Scharfenberg et al., 2020 | ||
| Elongation factor 1-beta (EF-1-beta) | O70251 | 2-225 | peptide-Ala40+Val-peptide | N | MS | Val | Phe | Glu | Ala | Val | Ser | Gly | Pro | Scharfenberg et al., 2020 | ||
| Envelope glycoprotein | P87671 | 33-676 | peptide-Asp637+Gln-peptide | N | MS | Thr | Leu | Pro | Asp | Gln | Gly | Asp | Asn | Dolnik et al., 2004 | ||
| EREG epiregulin preproprotein | O14944 | 102-114 | peptide-Leu108+Thr-peptide | N | His | Phe | Phe | Leu | Thr | Val | His | Gln | Sunnarborg et al., 2002 | 26301 | ||
| EREG epiregulin preproprotein | O14944 | 57-68 | peptide-Gln62+Val-peptide | N | Arg | Val | Ala | Gln | Val | Ser | Ile | Thr | Sunnarborg et al., 2002 | 26302 | ||
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3A | Q8R050-2 | 1-636 | peptide-Tyr233+Leu-peptide | N | MS | Gln | Ile | Met | Tyr | Leu | Thr | Gly | Met | Scharfenberg et al., 2020 | ||
| Eukaryotic translation initiation factor 2A (eIF-2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally pr | Q8BJW6 | 1-581 | peptide-Val19+Asn-peptide | N | MS | Leu | Tyr | Met | Val | Asn | Gly | Pro | Pro | Scharfenberg et al., 2020 | ||
| Ezrin (Cytovillin) (Villin-2) (p81) | P26040 | 1-586 | peptide-Glu502+Leu-peptide | N | MS | Tyr | Ser | Ala | Glu | Leu | Ser | Ser | Glu | Scharfenberg et al., 2020 | ||
| Ezrin (Cytovillin) (Villin-2) (p81) | P26040 | 1-586 | peptide-Glu502+Leu-peptide | N | MS | Tyr | Ser | Ala | Glu | Leu | Ser | Ser | Glu | Scharfenberg et al., 2020 | ||
| Ezrin (Cytovillin) (Villin-2) (p81) | P26040 | 1-586 | peptide-Gly498+Tyr-peptide | N | MS | Glu | Pro | Met | Gly | Tyr | Ser | Ala | Glu | Scharfenberg et al., 2020 | ||
| Ezrin (Cytovillin) (Villin-2) (p81) | P26040 | 1-586 | peptide-Arg350+Leu-peptide | N | MS | Leu | Met | Leu | Arg | Leu | Gln | Asp | Tyr | Scharfenberg et al., 2020 | ||
| Fibronectin (FN) [Cleaved into: Anastellin] | P11276 | 33-2477 | peptide-Pro1654+Ser-peptide | N | MS | Arg | Trp | Leu | Pro | Ser | Thr | Ser | Pro | Scharfenberg et al., 2020 | ||
| Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-mus | Q8BTM8 | 2-2647 | peptide-Ala1284+Leu-peptide | N | MS | Asp | Ala | Arg | Ala | Leu | Thr | Gln | Thr | Scharfenberg et al., 2020 | ||
| Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) | Q923D2 | 1-206 | peptide-Ala162+Tyr-peptide | N | MS | Leu | Thr | Gly | Ala | Tyr | Thr | Val | Thr | Scharfenberg et al., 2020 | ||
| Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Aldolase 1) (Muscle-type aldolase) | P05064 | 2-364 | peptide-Gln45+Ser-peptide | N | MS | Lys | Arg | Leu | Gln | Ser | Ile | Gly | Thr | Scharfenberg et al., 2020 | ||
| Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Aldolase 1) (Muscle-type aldolase) | P05064 | 2-364 | peptide-Arg43+Leu-peptide | N | MS | Ile | Ala | Lys | Arg | Leu | Gln | Ser | Ile | Scharfenberg et al., 2020 | ||
| Glu(EDANS)-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | Glu(EDANS)-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser(TF)-Ser-Lys(DABCYL) | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Minond et al., 2012 | |||||
| Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chai | O08795 | 15-521 | peptide-Ala358+Ile-peptide | N | MS | Glu | Thr | Gln | Ala | Ile | Ile | Asp | Ala | Scharfenberg et al., 2020 | ||
| growth hormone receptor precursor | P19941 | 19-638 | peptide-Pro256+Phe-peptide | P | Gln | Met | Ser | Pro | Phe | Thr | Cys | Glu | Wang et al., 2002 | 18995 | ||
| H-2 class I histocompatibility antigen, D-B alpha chain (H-2D(B)) | P01899 | 25-362 | peptide-Arg30+Tyr-peptide | N | MS | His | Ser | Met | Arg | Tyr | Phe | Glu | Thr | Scharfenberg et al., 2020 | ||
| Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) | P63017 | 2-646 | peptide-Ala180+Ile-peptide | N | MS | Thr | Ala | Ala | Ala | Ile | Ala | Tyr | Gly | Scharfenberg et al., 2020 | ||
| Heat shock protein beta-1 (HspB1) (Growth-related 25 kDa protein) (Heat shock 25 kDa protein) (HSP 25) (Heat shock 27 kDa protei | P14602 | 1-209 | peptide-Gln84+Leu-peptide | N | MS | Leu | Asn | Arg | Gln | Leu | Ser | Ser | Gly | Scharfenberg et al., 2020 | ||
| Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Tumor-specific transplantation 86 kDa antigen) (TSTA) | P07901 | 2-733 | peptide-Leu672+Leu-peptide | N | MS | Glu | Thr | Ala | Leu | Leu | Ser | Ser | Gly | Scharfenberg et al., 2020 | ||
| heparin-binding EGF-like growth factor precursor | Q99075 | 20-208 | peptide-Arg31+Gly-peptide | P | Arg | Leu | Arg | Arg | Gly | Leu | Ala | Ala | Hinkle et al., 2004 | 19482 | ||
| heparin-binding EGF-like growth factor precursor | Q99075 | 20-208 | peptide-Pro149+Val-peptide | P | Leu | Ser | Leu | Pro | Val | Glu | Asn | Arg | Hinkle et al., 2004 | 26303 | ||
| heparin-binding EGF-like growth factor precursor | Q06186 | 24-208 | peptide-Pro149+Val-peptide | P | Leu | Thr | Leu | Pro | Val | Glu | Asn | Pro | Hinkle et al., 2004 | 20162 | ||
| heparin-binding EGF-like growth factor precursor | Q06186 | 24-208 | peptide-Leu33+Ala-peptide | P | Arg | Arg | Gly | Leu | Ala | Ala | Ala | Thr | Hinkle et al., 2004 | |||
| heparin-binding EGF-like growth factor precursor | Q99075 | 20-208 | peptide-Arg62+Asp-peptide | P | Arg | Lys | Val | Arg | Asp | Leu | Gln | Glu | Hinkle et al., 2004 | |||
| heparin-binding EGF-like growth factor precursor | Q99075 | 20-208 | peptide-Leu72+Arg-peptide | P | Leu | Asp | Leu | Leu | Arg | Val | Thr | Leu | Hinkle et al., 2004 | |||
| heparin-binding EGF-like growth factor precursor | Q99075 | 20-208 | peptide-Arg73+Val-peptide | P | Asp | Leu | Leu | Arg | Val | Thr | Leu | Ser | Hinkle et al., 2004 | |||
| Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A) | Q99020 | 1-285 | peptide-Lys131+Val-peptide | N | MS | Ser | Val | Glu | Lys | Val | Leu | Asp | Gln | Scharfenberg et al., 2020 | ||
| Heterogeneous nuclear ribonucleoprotein F (hnRNP F) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally proce | Q9Z2X1-2 | 2-395 | peptide-Ser183+Val-peptide | N | MS | Lys | Phe | Met | Ser | Val | Gln | Arg | Pro | Scharfenberg et al., 2020 | ||
| Heterogeneous nuclear ribonucleoprotein F (hnRNP F) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally proce | Q9Z2X1-2 | 2-395 | peptide-Ser183+Val-peptide | N | MS | Lys | Phe | Met | Ser | Val | Gln | Arg | Pro | Scharfenberg et al., 2020 | ||
| Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1) | O88569-3 | 1-301 | peptide-Lys265+Ser-peptide | N | MS | Gly | Pro | Met | Lys | Ser | Gly | Asn | Phe | Scharfenberg et al., 2020 | ||
| Histidine triad nucleotide-binding protein 1 | P70349 | 2-126 | peptide-Lys30+Ile-peptide | N | MS | Ile | Pro | Ala | Lys | Ile | Ile | Phe | Glu | Scharfenberg et al., 2020 | ||
| IL6R | P08887 | 20-468 | peptide-Gln357+Asp-peptide | P | Leu | Pro | Val | Gln | Asp | Ser | Ser | Ser | Althoff et al., 2000 | 18753 | ||
| insulin B-chain (oxidized) | P01317 | 25-54 | Phe-Val-Asn-Gln-His-Leu-Cya-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr+Leu-Val-Cya-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Ala | N | Glu | Ala | Leu | Tyr | Leu | Val | Cya | Gly | Chesneau et al., 2003 | |||
| interleukin-6 receptor subunit alpha | P08887 | 20-468 | peptide-Pro355+Val-peptide | P | NT | Thr | Ser | Leu | Pro | Val | Gln | Asp | Ser | Riethmueller et al., 2017 | ||
| kit ligand | P20826 | 26-273 | peptide-Ala190+Ser-peptide | P | Pro | Val | Ala | Ala | Ser | Ser | Leu | Arg | Kawaguchi et al., 2007 | 20077 | ||
| KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) | Q8BX02-2 | 1-843 | peptide-Asp450+Lys-peptide | N | MS | Asp | Thr | Thr | Asp | Lys | Lys | Pro | Thr | Scharfenberg et al., 2020 | ||
| L-selectin processing site peptide | P14151 | 318-332 | ac-Lys-Leu-Asp-Lys+Ser-Phe-Ser-Met-Ile-Lys-Glu-Gly-Asp-Tyr-Asn-NH2 | N | Lys | Leu | Asp | Lys | Ser | Phe | Ser | Met | Peschon et al., 1998 | 18752 | ||
| Lamina-associated polypeptide 2, isoforms alpha/zeta (Thymopoietin isoforms alpha/zeta) (TP alpha/zeta) | Q61033-2 | 1-225 | peptide-Pro162+Thr-peptide | N | MS | Thr | Pro | Leu | Pro | Thr | Val | Ser | Ser | Scharfenberg et al., 2020 | ||
| Lamina-associated polypeptide 2, isoforms alpha/zeta (Thymopoietin isoforms alpha/zeta) (TP alpha/zeta) | Q61033-2 | 1-225 | peptide-Pro75+Val-peptide | N | MS | Glu | Pro | Thr | Pro | Val | Leu | Gly | Ser | Scharfenberg et al., 2020 | ||
| Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (FLI-LRR-associated protein 1) (Flap-1) (H | Q3UZ39 | 2-729 | peptide-Ala77+Ser-peptide | N | MS | Ala | Thr | Leu | Ala | Ser | Leu | Gly | Gly | Scharfenberg et al., 2020 | ||
| Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) | P70699 | 70-953 | peptide-Lys118+Glu-peptide | N | MS | Gln | Val | Leu | Lys | Glu | Pro | Gln | Ile | Scharfenberg et al., 2020 | ||
| Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) | P70699 | 70-953 | peptide-Gly453+Ser-peptide | N | MS | Gly | Pro | Ala | Gly | Ser | Tyr | Arg | Pro | Scharfenberg et al., 2020 | ||
| Macrophage colony-stimulating factor 1 (CSF-1) (MCSF) [Cleaved into: Processed macrophage colony-stimulating factor 1] | P07141 | 33-552 | peptide-Pro217+Leu-peptide | N | MS | Ser | Met | Ala | Pro | Leu | Ala | Gly | Leu | Scharfenberg et al., 2020 | ||
| macrophage colony-stimulating factor 1 receptor | P09581 | 20-977 | peptide-Gln503+Ser-peptide | P | NT | Ser | Leu | Gly | Gln | Ser | Lys | Gln | Leu | Vahidi et al., 2014 | ||
| major prion protein | P04156 | 23-253 | peptide-His111+Met-peptide | N | Asn | Met | Lys | His | Met | Ala | Gly | Ala | Alfa Cisse et al., 2007 | 20151 | ||
| Mca-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Lys(Dnp)-NH2 | Mca-Ser-Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser-Arg-Lys(Dnp)-NH2 | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Amour et al., 1998 | |||||
| Mca-Ser-Ser-Met-Ala-Gln-Thr-Leu-Thr-Leu-Arg-Ser-Ser-Ser-Lys(Dnp)-NH2 | Mca-Ser-Ser-Met-Ala-Gln-Thr-Leu-Thr+Leu-Arg-Ser-Ser-Ser-Lys(Dnp)-NH2 | S | Gln | Thr | Leu | Thr | Leu | Arg | Ser | Ser | Amour et al., 1998 | |||||
| Mediator of DNA damage checkpoint protein 1 | Q5PSV9 | 1-1707 | peptide-Thr470+Val-peptide | N | MS | Glu | Ala | Leu | Thr | Val | Thr | Gln | Pro | Scharfenberg et al., 2020 | ||
| meprin A subunit beta | Q16820 | 62-701 | peptide-Pro602+Ser-peptide | P | MS | Thr | Pro | Ala | Pro | Ser | Val | Gln | Asp | Werny et al., 2022 | ||
| Methionine-R-sulfoxide reductase B3, mitochondrial (MsrB3) (EC 1.8.4.-) | Q8BU85 | 57-253 | peptide-His75+Leu-peptide | N | MS | Asn | Leu | Leu | His | Leu | Val | Thr | Lys | Scharfenberg et al., 2020 | ||
| Methylosome subunit pICln | Q61189 | 2-236 | Ser-Phe3+Leu-peptide | N | MS | - | - | Ser | Phe | Leu | Lys | Ser | Phe | Scharfenberg et al., 2020 | ||
| Microtubule-associated protein 1B (MAP-1B) (MAP1(X)) (MAP1.2) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] | P14873 | 2-2464 | peptide-Tyr1061+Leu-peptide | N | MS | Gln | Tyr | Gly | Tyr | Leu | Gly | Thr | Ser | Scharfenberg et al., 2020 | ||
| Microtubule-associated protein 4 (MAP-4) | P27546-4 | 2-902 | peptide-Arg742+Leu-peptide | N | MS | Arg | Val | Ser | Arg | Leu | Ala | Thr | Thr | Scharfenberg et al., 2020 | ||
| Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1) | Q61166 | 2-268 | peptide-Lys204+Leu-peptide | N | MS | Lys | Val | Leu | Lys | Leu | Thr | Val | Glu | Scharfenberg et al., 2020 | ||
| Mitochondrial import inner membrane translocase subunit Tim13 | P62075 | 1-95 | peptide-Ala31+Val-peptide | N | MS | Val | Gln | Ile | Ala | Val | Ala | Asn | Ala | Scharfenberg et al., 2020 | ||
| myelin basic protein | P02687 | 1-169 | peptide-Ala16+Ser-peptide | P | Leu | Ala | Ser | Ala | Ser | Thr | Met | Asp | Chesneau et al., 2003 | 20191 | ||
| myelin basic protein | P02687 | 1-169 | peptide-Arg63+Thr-peptide | P | His | Ala | Ala | Arg | Thr | Thr | His | Tyr | Chesneau et al., 2003 | 20192 | ||
| myelin basic protein | P02687 | 1-169 | peptide-Phe88+Phe-peptide | P | Val | Val | His | Phe | Phe | Lys | Asn | Ile | Chesneau et al., 2003 | 20193 | ||
| myelin basic protein | P02687 | 1-169 | peptide-Ala14+Ser-peptide | P | Lys | Tyr | Leu | Ala | Ser | Ala | Ser | Thr | Chesneau et al., 2003 | 20194 | ||
| Myosin light chain 4 (MLC1EMB) (Myosin light chain 1, atrial/fetal isoform) (MLC1A) | P09541 | 2-193 | peptide-Arg121+Asn-peptide | N | MS | His | Ile | Ser | Arg | Asn | Lys | Glu | Gln | Scharfenberg et al., 2020 | ||
| neurogenic locus notch homolog protein 1 | Q01705 | 19-2531 | peptide-Ala1710+Val-peptide | P | Lys | Ile | Glu | Ala | Val | Lys | Ser | Glu | Brou et al., 2000 | |||
| neurogenic locus notch homolog protein 1 precursor | P46531 | 19-2555 | peptide-Gly1753+Val-peptide | P | Val | Gly | Cys | Gly | Val | Leu | Leu | Ser | Schroeter et al., 1998 | 4019 | ||
| Nptxr neuronal pentraxin receptor | Q99J85 | 1-493 | peptide-Ala35+Leu-peptide | P | Pro | Ala | Arg | Ala | Leu | Pro | Gly | Gly | Cho et al., 2008 | 22595 | ||
| Nptxr neuronal pentraxin receptor | Q99J85 | 1-493 | peptide-Ala175+Asp-peptide | P | Asp | Thr | Met | Ala | Asp | Gly | Ala | Trp | Cho et al., 2008 | 22596 | ||
| Nucleolin (Protein C23) | P09405 | 2-707 | peptide-Tyr464+Tyr-peptide | N | MS | Val | Ser | Leu | Tyr | Tyr | Thr | Gly | Glu | Scharfenberg et al., 2020 | ||
| Phosphoglycerate kinase 2 (EC 2.7.2.3) (Phosphoglycerate kinase, testis specific) | P09041 | 1-417 | peptide-Leu157+Gly-peptide | N | MS | Leu | Ser | Lys | Leu | Gly | Asp | Val | Tyr | Scharfenberg et al., 2020 | ||
| Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) (Heart adapter protein 1) | Q3UIL6-3 | 1-1118 | peptide-Ser895+Leu-peptide | N | MS | Pro | Ser | Leu | Ser | Leu | Val | Gly | Ser | Scharfenberg et al., 2020 | ||
| Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) | P60335 | 1-356 | peptide-Pro191+Val-peptide | N | MS | Ala | Ser | Ser | Pro | Val | Ile | Cys | Ala | Scharfenberg et al., 2020 | ||
| Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) | P60335 | 1-356 | peptide-Pro187+Ala-peptide | N | MS | Gln | Pro | Met | Pro | Ala | Ser | Ser | Pro | Scharfenberg et al., 2020 | ||
| Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protei | Q8CCS6-2 | 2-292 | peptide-Ala7+Ala-peptide | N | MS | Ala | Ala | Ala | Ala | Ala | Ala | Ala | Ala | Scharfenberg et al., 2020 | ||
| Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK homol | P54823 | 1-483 | peptide-Gly13+Leu-peptide | N | MS | Val | Ile | Met | Gly | Leu | Ser | Ser | Gln | Scharfenberg et al., 2020 | ||
| Procollagen C-endopeptidase enhancer 1 | Q61398 | 25-468 | peptide-Pro118+Val-peptide | N | MS | Arg | Pro | Ala | Pro | Val | Val | Ala | Pro | Scharfenberg et al., 2020 | ||
| Procollagen C-endopeptidase enhancer 1 | Q61398 | 25-468 | peptide-Glu95+Val-peptide | N | MS | Asp | Ala | Leu | Glu | Val | Phe | Ala | Gly | Scharfenberg et al., 2020 | ||
| Procollagen C-endopeptidase enhancer 1 | Q61398 | 25-468 | peptide-Gly112+Thr-peptide | N | MS | Arg | Phe | Cys | Gly | Thr | Phe | Arg | Pro | Scharfenberg et al., 2020 | ||
| proepiregulin | O14944 | 29-169 | peptide-Arg59+Val-peptide | P | NT | Asp | Asn | Pro | Arg | Val | Ala | Gln | Val | Minond et al., 2012 | ||
| Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19) | P56812 | 2-126 | peptide-Glu16+Leu-peptide | N | MS | Arg | Leu | Ala | Glu | Leu | Gln | Ala | Lys | Scharfenberg et al., 2020 | ||
| Protein CDV3 (Carnitine deficiency-associated protein 3) (Tyrosine-phosphorylated protein 36) (TPP36) | Q4VAA2-2 | 2-281 | peptide-Ala127+Met-peptide | N | MS | Arg | Val | Gln | Ala | Met | Gln | Ile | Ser | Scharfenberg et al., 2020 | ||
| Protein disulfide-isomerase A3 | P27773 | 25-505 | peptide-Phe171+Leu-peptide | N | MS | His | Ser | Glu | Phe | Leu | Lys | Ala | Ala | Scharfenberg et al., 2020 | ||
| Protein enabled homolog (NPC-derived proline-rich protein 1) (NDPP-1) | Q03173-2 | 1-802 | peptide-Pro299+Ile-peptide | N | MS | Asp | Ala | Glu | Pro | Ile | Thr | Ala | Lys | Scharfenberg et al., 2020 | ||
| Protein lin-7 homolog C (Lin-7C) (mLin7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3) | O88952 | 2-197 | peptide-Phe82+Ala-peptide | N | MS | Val | Ala | Ala | Phe | Ala | Ala | Ser | Glu | Scharfenberg et al., 2020 | ||
| Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Ndr2) | Q9QYG0-2 | 2-357 | peptide-Ser318+Leu-peptide | N | MS | Arg | Thr | Ala | Ser | Leu | Thr | Ser | Ala | Scharfenberg et al., 2020 | ||
| Protein phosphatase 1 regulatory subunit 14B (Phosphatase holoenzyme inhibitor 1) (PHI-1) (Phospholipase C-beta-3 neighbouring g | Q62084 | 2-147 | peptide-Ala15+Leu-peptide | N | MS | Gly | Gly | Ala | Ala | Leu | Ala | Ala | Pro | Scharfenberg et al., 2020 | ||
| Protein phosphatase inhibitor 2 (IPP-2) | Q9DCL8 | 2-206 | peptide-Lys104+Leu-peptide | N | MS | Leu | Ala | Lys | Lys | Leu | Ala | Ala | Ala | Scharfenberg et al., 2020 | ||
| Protein PRRC2C (BAT2 domain-containing protein 1) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containin | Q3TLH4-5 | 1-2846 | peptide-Ala415+Gln-peptide | N | MS | Lys | Leu | Leu | Ala | Gln | Gln | His | Pro | Scharfenberg et al., 2020 | ||
| protransforming growth factor alpha precursor | P01135 | 24-160 | peptide-Ala16+Val-peptide | P | Val | Ala | Ala | Ala | Val | Val | Ser | His | Hinkle et al., 2003 | 19489 | ||
| protransforming growth factor alpha precursor | P01135 | 24-160 | peptide-Ala66+Val-peptide | P | Asp | Leu | Leu | Ala | Val | Val | Ala | Ala | Sunnarborg et al., 2002 | 16950 | ||
| Radixin (ESP10) | P26043 | 1-583 | peptide-Arg330+Glu-peptide | N | MS | Lys | Lys | Lys | Arg | Glu | Ile | Ala | Glu | Scharfenberg et al., 2020 | ||
| Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2) | P97379-2 | 1-482 | peptide-Pro237+Ala-peptide | N | MS | Pro | Ala | Glu | Pro | Ala | Ser | Leu | Pro | Scharfenberg et al., 2020 | ||
| receptor tyrosine-protein kinase erbB-4 | Q15303 | 26-1308 | peptide-His641+Ser-peptide | P | NT | Trp | Thr | Gly | His | Ser | Thr | Leu | Pro | Cheng et al., 2003 | 18831 | |
| Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (GDI-1) (Rho-GDI alpha) | Q99PT1 | 2-204 | peptide-Lys33+Ser-peptide | N | MS | Pro | Ala | Gln | Lys | Ser | Ile | Gln | Glu | Scharfenberg et al., 2020 | ||
| Scaffold attachment factor B1 (SAF-B1) | D3YXK2 | 2-937 | peptide-Ala244+Thr-peptide | N | MS | Phe | Ala | Gln | Ala | Thr | Ser | Ser | Val | Scharfenberg et al., 2020 | ||
| Serpin H1 (47 kDa heat shock protein) (Collagen-binding protein) (Colligin) (Serine protease inhibitor J6) | P19324 | 18-417 | peptide-Lys34+Leu-peptide | N | MS | Thr | Ala | Glu | Lys | Leu | Ser | Ser | Lys | Scharfenberg et al., 2020 | ||
| Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) | P16546-2 | 1-2452 | peptide-Leu1208+Leu-peptide | N | MS | Arg | Ser | Gln | Leu | Leu | Gly | Ser | Ala | Scharfenberg et al., 2020 | ||
| Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) | P16546-2 | 1-2452 | peptide-Gln1207+Leu-peptide | N | MS | Glu | Arg | Ser | Gln | Leu | Leu | Gly | Ser | Scharfenberg et al., 2020 | ||
| Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (U2 snRNP auxiliary factor large subunit) | P26369 | 2-475 | peptide-Pro138+Val-peptide | N | MS | Thr | Pro | Val | Pro | Val | Val | Gly | Ser | Scharfenberg et al., 2020 | ||
| Stress-induced-phosphoprotein 1 (STI1) (mSTI1) (Hsc70/Hsp90-organizing protein) (Hop) | Q60864 | 1-543 | peptide-Ala+Val-peptide | N | MS | Asn | Gln | Ala | Ala | Val | His | Phe | Glu | Scharfenberg et al., 2020 | ||
| Talin-1 | P26039 | 1-2541 | peptide-Ala1904+Val-peptide | N | MS | Lys | Pro | Ala | Ala | Val | Ala | Ala | Glu | Scharfenberg et al., 2020 | ||
| Thrombospondin-4 | Q9Z1T2 | 27-963 | peptide-Ala214+Ala-peptide | N | MS | Glu | Pro | Leu | Ala | Ala | Thr | Ser | Thr | Scharfenberg et al., 2020 | ||
| TNFtide (PLAQAVRSS) | P01375 | 72-80 | Pro-Leu-Ala-Gln-Ala+Val-Arg-Ser-Ser | S | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | Liu et al., 2014 | |||
| TNFtide4A (PLAAAVRSS) | P01375 | 72-80 | Pro-Leu-Ala-Ala-Ala+Val-Arg-Ser-Ser | S | Leu | Ala | Ala | Ala | Val | Arg | Ser | Ser | Liu et al., 2014 | |||
| TNFtide4A7F (PLAAAVFSS) | P01375 | 72-80 | Pro-Leu-Ala-Ala-Ala+Val-Phe-Ser-Ser | S | Leu | Ala | Ala | Ala | Val | Phe | Ser | Ser | Liu et al., 2014 | |||
| TNFtide7F (PLAQAVFSS | P01375 | 72-80 | Pro-Leu-Ala-Gln-Ala+Val-Phe-Ser-Ser | S | Leu | Ala | Gln | Ala | Val | Phe | Ser | Ser | Liu et al., 2014 | |||
| Transcription factor Sp5 | Q9JHX2 | 1-398 | peptide-Ala34+Leu-peptide | N | MS | Ser | Pro | Leu | Ala | Leu | Leu | Ala | Ala | Scharfenberg et al., 2020 | ||
| transferrin receptor protein 1 | P02786 | 1-760 | peptide-Arg100+Leu-peptide | P | NT | Glu | Cys | Glu | Arg | Leu | Ala | Gly | Thr | Minond et al., 2012 | ||
| Transketolase (TK) (EC 2.2.1.1) (P68) | P40142 | 1-623 | peptide-Lys11+Leu-peptide | N | MS | Asp | Gln | Gln | Lys | Leu | Gln | Ala | Leu | Scharfenberg et al., 2020 | ||
| Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase) | P17751 | 2-249 | peptide-Gly172+Thr-peptide | N | MS | Trp | Ala | Ile | Gly | Thr | Gly | Lys | Thr | Scharfenberg et al., 2020 | ||
| Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase) | P17751 | 2-249 | peptide-Trp192+Leu-peptide | N | MS | Leu | Arg | Gly | Trp | Leu | Lys | Ser | Asn | Scharfenberg et al., 2020 | ||
| Tubulin alpha-1B chain (Alpha-tubulin 2) (Alpha-tubulin isotype M-alpha-2) (Tubulin alpha-2 chain) [ | P05213 | 1-451 | peptide-Gln91+Leu-peptide | N | MS | His | Pro | Glu | Gln | Leu | Ile | Thr | Gly | Scharfenberg et al., 2020 | ||
| tumor necrosis factor | P01375 | 1-233 | peptide-Ala76+Val-peptide | P | Leu | Ala | Gln | Ala | Val | Arg | Ser | Ser | 4017 | |||
| tumor necrosis factor ligand superfamily member 11 | Q3TWY5 | 1-316 | peptide-Arg138+Phe-peptide | P | Gly | Pro | Gln | Arg | Phe | Ser | Gly | Ala | Lum et al., 1999 | 19217 | ||
| tumor necrosis factor receptor superfamily member 16 | Q9Z0W1 | 225-240 | Val-Thr-Thr-Val-Met-Gly-Ser-Ser-Gln-Pro+Val-Val-Thr-Arg-Gly-Thr | N | Ser | Ser | Gln | Pro | Val | Val | Thr | Arg | Weskamp et al., 2004 | |||
| Twinfilin-1 (Protein A6) | Q91YR1 | 2-350 | peptide-Pro146+Leu-peptide | N | MS | Ser | Pro | Ala | Pro | Leu | Thr | Ala | Ala | Scharfenberg et al., 2020 | ||
| Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) | P56399 | 2-858 | peptide-Ala419+Leu-peptide | N | MS | Met | Phe | Lys | Ala | Leu | Ile | Gly | Lys | Scharfenberg et al., 2020 | ||
| Ubiquitin-like modifier-activating enzyme 1 | Q02053 | 2-1058 | peptide-Phe861+Ile-peptide | N | MS | His | Met | Asp | Phe | Ile | Val | Ala | Ala | Scharfenberg et al., 2020 | ||
| Ubiquitin-like modifier-activating enzyme 1 | Q02053 | 2-1058 | peptide-Phe861+Ile-peptide | N | MS | His | Met | Asp | Phe | Ile | Val | Ala | Ala | Scharfenberg et al., 2020 | ||
| UV excision repair protein RAD23 homolog B (HR23B) (mHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58) | P54728 | 1-416 | peptide-Ala259+Ala-peptide | N | MS | Val | Ala | Ala | Ala | Ala | Ala | Thr | Thr | Scharfenberg et al., 2020 | ||
| Vimentin | P20152 | 2-466 | peptide-Pro432+Leu-peptide | N | MS | Glu | Ser | Leu | Pro | Leu | Val | Asp | Thr | Scharfenberg et al., 2020 | ||
| Vimentin | P20152 | 2-466 | peptide-Pro416+Thr-peptide | N | MS | Leu | Pro | Leu | Pro | Thr | Phe | Ser | Ser | Scharfenberg et al., 2020 | ||
| Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Y-box protein 3) | Q9JKB3-2 | 2-292 | peptide-Pro223+Ala-peptide | N | MS | Arg | Pro | Ala | Pro | Ala | Ile | Gly | Glu | Scharfenberg et al., 2020 | ||
| Zinc finger protein ZPR1 (Zinc finger protein 259) | Q62384 | 1-459 | peptide-Gly237+Leu-peptide | N | MS | Glu | Met | Leu | Gly | Leu | Gln | Ala | Glu | Scharfenberg et al., 2020 | ||
| Zinc finger RNA-binding protein | O88532 | 1-1074 | peptide-Ala556+Leu-peptide | N | MS | Ser | Leu | Ala | Ala | Leu | Gln | Ser | Asp | Scharfenberg et al., 2020 | ||
| Zyxin | Q62523 | 2-564 | peptide-Pro235+Val-peptide | N | MS | Gln | Pro | Gln | Pro | Val | Ser | Ser | Ala | Scharfenberg et al., 2020 |
